Taysha Gene Therapies nabs $95m Series B

Dallas-based Taysha Gene Therapies, a gene therapy company, has raised $95 million in Series B financing.

Dallas-based Taysha Gene Therapies, a gene therapy company, has raised $95 million in Series B financing. Fidelity Management & Research Company LLC led the round with participation from other investors that included BlackRock, GV, Invus, Casdin Capital, Franklin Templeton, Octagon Capital, Perceptive Advisors LLC, Sands Capital, ArrowMark Partners, Venrock Healthcare Capital Partners, PBM Capital and Nolan Capital

Source: Press Release